Healius declares $300m bonus for shareholders and draws in buyers

SYDNEY: Pathology services provider Healius has outlined a $300 million special dividend payout ... read more

Healthscope suitors offered due diligence with sale afoot

SYDNEY: Suitors interested in buying Brookfield’s embattled private hospital operator Healthscope will be ... read more

Brookefield set to weigh up buyer interest for Aveo

SYDNEY: Brookfield is expected to gain further insight by the end of the ... read more

Clinical trial result from hell has biotech investors on edge

MELBOURNE: For three decades, Megan Baldwin dedicated her life to taking her PhD ... read more